Literature DB >> 10751889

Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads.

M Liebman1, G Costa.   

Abstract

PURPOSE: Urinary oxalate is a primary determinant of the level of calcium oxalate saturation and the formation of calcium oxalate crystals, a key event in kidney stone formation. The primary objective of this study was to compare the effects of calcium carbonate and magnesium oxide on oxalate absorption.
MATERIALS AND METHODS: An experimental model was used that allowed differentiation between endogenously and oxalate load-derived urinary oxalate. Twenty-four healthy subjects (10 males, 14 females) participated in three oxalate load (OL) tests: control (OL alone), calcium carbonate (OL with concomitant calcium carbonate ingestion), and magnesium oxide (OL with concomitant magnesium oxide ingestion). Oxalate loads consisted of 180 mg. unlabeled and 18 mg. 1,2[13C2] oxalic acid. Timed urine samples were collected after the OL for analysis of oxalate, calcium, magnesium, and creatinine.
RESULTS: Both the calcium carbonate and magnesium oxide treatments were associated with significantly lower load-derived oxalate levels at all time points within the initial 24-hour post-oxalate ingestion period compared with levels observed for the control treatment. There were no treatment effects on endogenous oxalate levels. The efficiency of oxalate absorption for the calcium carbonate (5.1%) and magnesium oxide (7.6%) treatments was significantly lower than that for the control treatment (13.5%).
CONCLUSIONS: The results suggested that magnesium was nearly as effective as calcium in reducing oxalate absorption and urinary excretion. Higher levels of urinary oxalate, calcium, and magnesium in males appeared to be largely a function of body size since gender differences either disappeared or were reversed when a correction was made for urinary creatinine excretion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751889

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  26 in total

1.  Comparison of the Effects of Vaginal Royal Jelly and Vaginal Estrogen on Quality of Life, Sexual and Urinary Function in Postmenopausal Women.

Authors:  Fatemeh Seyyedi; Mahmoud Rafiean-Kopaei; Sepideh Miraj
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 2.  Intestinal transport of an obdurate anion: oxalate.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Urol Res       Date:  2004-11-25

3.  Influence of a high-oxalate diet on intestinal oxalate absorption.

Authors:  Diana J Zimmermann; Albrecht Hesse; Gerd E von Unruh
Journal:  World J Urol       Date:  2005-11-05       Impact factor: 4.226

4.  Parsley! Mechanism as antiurolithiasis remedy.

Authors:  Fayed Al-Yousofy; Hussein Gumaih; Hassan Ibrahim; Afrah Alasbahy
Journal:  Am J Clin Exp Urol       Date:  2017-11-09

5.  Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  Benjamin W Turney; Paul N Appleby; John M Reynard; Jeremy G Noble; Timothy J Key; Naomi E Allen
Journal:  Eur J Epidemiol       Date:  2014-04-22       Impact factor: 8.082

6.  Kinetics of calcium oxalate crystal formation in urine.

Authors:  Norbert Laube; Florian Klein; Falk Bernsmann
Journal:  Urolithiasis       Date:  2016-06-21       Impact factor: 3.436

7.  Dietary management of idiopathic hyperoxaluria and the influence of patient characteristics and compliance.

Authors:  Zeyad R Schwen; Julie M Riley; Yaniv Shilo; Timothy D Averch
Journal:  Urology       Date:  2013-09-17       Impact factor: 2.649

8.  Bioavailability of magnesium from different pharmaceutical formulations.

Authors:  Roswitha Siener; Andrea Jahnen; Albrecht Hesse
Journal:  Urol Res       Date:  2010-09-23

Review 9.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

Review 10.  Lowering urinary oxalate excretion to decrease calcium oxalate stone disease.

Authors:  Ross P Holmes; John Knight; Dean G Assimos
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.